ClinicalTrials.Veeva

Menu

Clinical Effect of MiboFlo in Dry Eye Patients

Capital Medical University logo

Capital Medical University

Status

Completed

Conditions

Meibomian Gland Dysfunction
Dry Eye Syndromes

Treatments

Device: MiBoFlo Thermoflo
Procedure: forceful expression of the meibomian glands
Device: LipiFlow

Study type

Interventional

Funder types

Other

Identifiers

NCT04310969
TRECKY2019-099

Details and patient eligibility

About

The aim of this prospective study is to compare the changes between the patients receiving traditional treatment and the patients with MiBoFlo, evaluating the effectiveness of MiBoFlo.

Full description

The MiBoFlo Thermoflo uses a proprietary thermoelectric heat pump to help meibum maximize liquefaction, improving the preservation and function of the tear film's evaporative component. It supplies continuous controlled heat to the outer skin of the eyelids, absorbing deep into the tissue and breaks down the hardened oils in the meibomian glands. We are trying to find a effective, safe and economical therapy for dry eye patients.

Enrollment

90 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age of older;
  • Meet the diagnostic criteria for dry eye developed by DEWS II: OSDI score≥15 points, TBUT≤10 minutes;
  • Meet the signs of meibomian gland dysfunction

Exclusion criteria

  • Had skin allergies or inflammation;
  • Had active ocular infection or inflammation;
  • Had history of ocular surgery, eyelid surgery or neurological paralysis within 6 months;
  • Had history of systemic disease affecting ocular surface function, such as Stevens-Johnson syndrome, Sjögren syndrome etc.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 3 patient groups

treatment group
Experimental group
Description:
Patients are treated every two weeks for a total of three times. Forceful expression of the meibomian glands is followed after each therapy.
Treatment:
Device: MiBoFlo Thermoflo
Procedure: forceful expression of the meibomian glands
control group
Sham Comparator group
Description:
Forceful expression of the meibomian glands only for patients.
Treatment:
Procedure: forceful expression of the meibomian glands
active control group
Active Comparator group
Description:
LipiFlow® treatment is used as an active comparator.
Treatment:
Device: LipiFlow

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems